TerminatedNCT01662297
Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed Veterans
Medication studyAges 18+United StatesAddiction
Understand this study
Who could participate?
This study is for people with insomnia. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- West HavenSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJuly 2012
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 1
- Sponsor
- VA Connecticut Healthcare System
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT01662297
- Official title
Show the full official title
Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed Veterans: an Open (e.g. Unblinded) Randomized Stay-Switch Pilot Trial
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
West Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is VA Connecticut Healthcare System.
Does this study involve medication?
Yes. The study involves medication, including Quetiapine and Trazodone.
Who can participate?
This study is for people with insomnia. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
